Development of an Effective Neutralizing Antibody Assay for SARS-CoV-2 Diagnosis.

Serum and blood samples were used under approval from the Biomedical Research Ethics Subcommittee of Henan University, and the clinical trial registration number was HUSOM-2022-052. We confirm that this study complies with the Declaration of Helsinki.